Latest Updates

60 students from 40 leading universities in 21 countries got the opportunity to explore science and innovation at Novartis…

Plans to launch more clinics in other select cities

Through the non-elcusive agreement, Avesthagen stands to earn $30 Million over the next decade

Panel discussion to focus on international collaborations in drug delivery science

Discusses the rise and challenges of drug-resistant TB in India

'Shapeshifting' computer programme will open up drug discovery for tricky disease targets

Forays into news territories together

Is indicated for the treatment of all forms of tuberculosis

Top policy makers and healthcare stakeholders offer rich insights for achieving efficient and affordable healthcare access for all…

New Frost & Sullivan report analysis which products will eventually succeed and why, in the race against time